Sartore‐Bianchi, A., Amatu, A., Porcu, L., Ghezzi, S., Lonardi, S., Leone, F., . . . Siena, S. (2019). HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer. Oncologist.
Chicago Stili AlıntıSartore‐Bianchi, Andrea, et al. "HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer." Oncologist 2019.
MLA AlıntıSartore‐Bianchi, Andrea, et al. "HER2 Positivity Predicts Unresponsiveness to EGFR‐Targeted Treatment in Metastatic Colorectal Cancer." Oncologist 2019.
Uyarı: Bu alıntı herzaman %100 doğru olmayabilir..